Ebitda Изменить Дата
AbbVie USD 6.91B 3.22B 2026-06
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.8B 1.25B 2026-09
Ardelyx USD -9.78M 19.98M 2026-06
Arrowhead Research USD -212.62M 64.94M 2026-09
Bayer EUR 1.62B 529M 2026-09
Biogen USD 450.8M 198.9M 2026-06
Corcept Therapeutics USD 115.75M 73.59M 2026-09
Curis USD -12.3M 231K 2023-09
Gilead Sciences USD -9.31B 12.82B 2026-06
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 8.62B 2.14B 2026-09
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
TG Therapeutics USD 89.8M 62.9M 2026-09
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09